Literature DB >> 19035337

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.

Yusuf Yilmaz, Engin Ulukaya, Enver Dolar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19035337     DOI: 10.1002/hep.22691

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Alla Eldeen Kedrah; Osman Ozdogan
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

2.  Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?

Authors:  Yusuf Yilmaz; Enver Dolar
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

3.  Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.

Authors:  Hong-Lei Ma; Kenneth I Zheng; Rafael S Rios; Liang-Jie Tang; Gang Li; Pei-Wu Zhu; Xiao-Dong Wang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

4.  Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins.

Authors:  Yong-Ning Xin; Ning Geng; Zhong-Hua Lin; Ya-Zhou Cui; Hai-Ping Duan; Mei Zhang; Shi-Ying Xuan
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

5.  Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis

Authors:  Saber A Ismail; Sherif El Saadany; Dina H Ziada; Soha S Zakaria; Wael W Mayah; Heba Elashry; Mona Arafa; Nehal Elmashad
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.